{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:12:20Z","timestamp":1778749940309,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004077","name":"Kocaeli University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.prp.2024.155765","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T02:58:55Z","timestamp":1734490735000},"page":"155765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic value of circulating and tumor microenvironmental biomarkers in endometrial cancer"],"prefix":"10.1016","volume":"266","author":[{"given":"Seda Duman","family":"\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gupse","family":"Turan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eener","family":"Gezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2024.155765_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/07357907.2021.2012188","article-title":"PD-1\/PD-L1 inhibitors monotherapy for the treatment of endometrial cancer: meta-analysis and systematic review","volume":"40","author":"Dai","year":"2022","journal-title":"Cancer Invest"},{"issue":"3","key":"10.1016\/j.prp.2024.155765_bib2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.21873\/anticanres.15606","article-title":"Programmed cell death ligand-1 (PDL-1) correlates with tumor infiltration by immune cells and represents a promising target for immunotherapy in endometrial cancer","volume":"42","author":"Hecking","year":"2022","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2024.155765_bib3","article-title":"Estrogen receptor and programmed death ligand-1 expression in type 1 endometrial cancer and its associated clinicopathological characteristics","volume":"37","author":"Waluyo","year":"2023","journal-title":"Cancer Treat. Res Commun."},{"issue":"2","key":"10.1016\/j.prp.2024.155765_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pathol.2015.12.006","article-title":"Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy","volume":"48","author":"Lee","year":"2016","journal-title":"Pathology"},{"issue":"12","key":"10.1016\/j.prp.2024.155765_bib5","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1245\/s10434-017-5796-4","article-title":"clinical impact of tumor- infiltrating lymphocytes in esophageal squamous cell carcinoma","volume":"24","author":"Sudo","year":"2017","journal-title":"Ann. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.prp.2024.155765_bib6","first-page":"2689","article-title":"Tumor-associated neutrophils in breast cancer subtypes","volume":"18","author":"Soto-Perez-de-Celis","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.prp.2024.155765_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12885-021-07789-6","article-title":"Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy","volume":"21","author":"Geng","year":"2021","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.prp.2024.155765_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/15384047.2020.1807250","article-title":"Tumor associated neutrophils promote the metastasis of pancreatic ductal adenocarcinoma","volume":"21","author":"Lianyuan","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2024.155765_bib9","first-page":"81","article-title":"Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data","volume":"12","author":"Pan","year":"2019","journal-title":"J. Res."},{"key":"10.1016\/j.prp.2024.155765_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2024.155765_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/neuonc\/nov172","article-title":"PD-L1 expression and prognostic impact in glioblastoma","volume":"18","author":"Nduom","year":"2016","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155765_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12885-020-06953-8","article-title":"Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer","volume":"20","author":"Cong","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.prp.2024.155765_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000497184","article-title":"Pretreatment neutrophil-to-lymphocyte ratio was a predictor of lymph node metastasis in endometrial cancer patients","volume":"96","author":"Aoyama","year":"2019","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.prp.2024.155765_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00125480-200101000-00002","article-title":"Tissue microarrays: what will they bring to molecular and anatomic pathology?","volume":"8","author":"Moch","year":"2001","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2024.155765_bib15","unstructured":"Hendry S., Salgado R., Gevaert T., et al. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno- Oncology BiomarkersWorking Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Adv Anat Pathol."},{"key":"10.1016\/j.prp.2024.155765_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152151","article-title":"The prognostic significance of non-lymphoid immune cells of the tumor microenvironment, including neutrophils, eosinophils, and mast cells in breast carcinomas","volume":"65","author":"Okcu","year":"2023","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2024.155765_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/01.MP.0000020391.98998.6B","article-title":"C. Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high- risk area in northern Italy","volume":"15","author":"Caruso","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155765_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/djy088","article-title":"AltmanDG. Reporting recommendations for tumormarker prognosticStudies (REMARK): an abridged explanation and elaboration","volume":"110","author":"Sauerbrei","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.prp.2024.155765_bib19","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155765_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-021-00301-z","article-title":"Immunotherapy in endometrial cancer: rationale, practice and perspectives","volume":"9","author":"Cao","year":"2021","journal-title":"Biomark. Res"},{"key":"10.1016\/j.prp.2024.155765_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","article-title":"Clinical significance of tumor-infiltrating lymphocytes in breast cancer","volume":"4","author":"Stanton","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2024.155765_bib22","doi-asserted-by":"crossref","unstructured":"Y. Wang, J. Zhai, T. Zhang, S. Han, Y. Zhang, X. Yao, L. Shen Tumor-associated neutrophils can predict lymph node metastasis in early gastric cancer Front Oncol, 21 (10) (2020 Sep), Article 570113, 10.3389\/ fonc.2020.570113 PMID: 33072602; PMCID: PMC7537418.","DOI":"10.3389\/fonc.2020.570113"},{"key":"10.1016\/j.prp.2024.155765_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopha.2017.08.003","article-title":"The prognostic landscape of tumor-infiltrating immune cell and immunomodulators in lung cancer","volume":"95","author":"Liu","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.prp.2024.155765_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1479-5876-12-151","article-title":"Synergistic effects of IL-4 and TNF\u03b1 on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation","volume":"12","author":"Quandt","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2024.155765_bib25","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/bjc.2015.101","article-title":"IFN-\u03b3 from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.","volume":"112","author":"Abiko","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2024.155765_bib26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/JTO.0000000000000500","article-title":"Upregulation of PD-L1 by EGFR activation mediates the immune escape in EGFR-driven NSCLC: implication for optional immune targeted therapy for NSCLC patients with EGFR mutation","volume":"10","author":"Chen","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2024.155765_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102257","article-title":"Discordance of PD-L1 status between primary and metastatic breast cancer: a systematic review and meta-analysis","volume":"99","author":"Boman","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"16","key":"10.1016\/j.prp.2024.155765_bib28","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.3390\/cancers14163911","article-title":"PD-L1 expression in endometrial cancer and its association with clinicopathological features: a systematic review and meta-analysis","volume":"14","author":"Mamat Yusof","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155765_bib29","doi-asserted-by":"crossref","unstructured":"Pasanen, Annukka MD*,\u2020; Ahvenainen, Terhi MSc\u2021,\u00a7; Pellinen, Teijo PhD\u2225; Vahteristo, Pia PhD\u2021,\u00a7; Loukovaara, Mikko MD, PhD\u00b6; B\u00fctzow, Ralf MD, PhD*,\u2020,\u00b6. PD-L1 Expression in Endometrial Carcinoma Cells and Intratumoral Immune Cells: Differences Across Histologic and TCGA-based Molecular Subgroups. The American Journal of Surgical Pathology 44(2):p 174-181, February 2020. | https:\/\/doi.org\/10.1097\/PAS.0000000000001395.","DOI":"10.1097\/PAS.0000000000001395"},{"issue":"5","key":"10.1016\/j.prp.2024.155765_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PGP.0000000000000543","article-title":"Expression of immunomodulatory molecules PD-1, PD-L1, and PD-L2, and their relationship with clinicopathologic characteristics in endometrial cancer","volume":"38","author":"Sungu","year":"2019","journal-title":"Int J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2024.155765_bib31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3892\/ol.2016.4744","article-title":"Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer","volume":"12","author":"Mo","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155765_bib32","unstructured":"Cong R., Kong F., Ma J., Li Q., Wu Q., Ma X. Combination of preoperative neutrophil- lymphocyte ratio, platelet-lymphocyte ratio and monocyte- lymphocyte ratio: a superior prognostic factor of endometrial cancer. BMC."},{"issue":"1","key":"10.1016\/j.prp.2024.155765_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00404-019-05372-w","article-title":"Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to- lymphocyte ratios in endometrial cancer: a systematic review and meta- analysis","volume":"301","author":"Ni","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.prp.2024.155765_bib34","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ygyno.2022.07.010","article-title":"Beyond mismatch repair deficiency? Pre- treatment neutrophil-to-lymphocyte ratio is associated with improved overall survival in patients with recurrent endometrial cancer treated with immunotherapy","volume":"166","author":"Barrington","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155765_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2021.11.009","article-title":"Pre- treatment inflammatory parameters predict survival from endometrial cancer: a prospective database analysis","volume":"164","author":"Njoku","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2024.155765_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9061721","article-title":"Immune checkpoint inhibitors: a promising choice for endometrial cancer patients?","volume":"9","author":"Musacchio","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.prp.2024.155765_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/07357907.2021.2012188","article-title":"PD-1\/PD-L1 inhibitors monotherapy for the treatment of endometrial cancer: meta-analysis and systematic review","volume":"40","author":"Dai","year":"2022","journal-title":"Cancer Invest"},{"issue":"13","key":"10.1016\/j.prp.2024.155765_bib38","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.3390\/jcm11133912","article-title":"Immune checkpoint inhibitors and mismatch repair status in advanced endometrial cancer: elective affinities","volume":"11","author":"Rizzo","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2024.155765_bib39","series-title":"Ther. Adv. Med. Oncol. 15","article-title":"A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer","author":"Tinker","year":"2023"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:29:48Z","timestamp":1778747388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824006769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":39,"alternative-id":["S0344033824006769"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155765","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of circulating and tumor microenvironmental biomarkers in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155765"}}